| Luliconazole Action Pathway |  | Drug Action | Formic acid / Mesoheme / Ergosterol / Luliconazole |
| Luliconazole Drug Metabolism |  | Metabolic | Luliconazole |
| Lumateperone Dopamine Action Action Pathway |  | Drug Action | Pyridoxal phosphate / Tyrosine / Sapropterin / Dopamine / Levodopa / Calcium / Iron / Lumateperone |
| Lumateperone Serotonin Antagonist Action Pathway |  | Drug Action | Pyridoxal phosphate / Tryptophan / Sapropterin / Calcium / Iron / Oxitriptan / Lumateperone |
| Lumateperone SSRI Action Action Pathway |  | Drug Action | Pyridoxal phosphate / Tryptophan / Sapropterin / Calcium / Iron / Oxitriptan / Lumateperone |
| Lumiracoxib Action Pathway |  | Drug Action | Glutamic acid / Glutathione / Dinoprostone / Lumiracoxib / Calcium / Magnesium cation / Zinc / Prostaglandin D2 / Mesoheme / Prostaglandin G2 / Arachidonic Acid |
| Lumiracoxib NSAID Action Pathway |  | Drug Action | Glutathione / Dinoprostone / Lumiracoxib / Calcium / Mesoheme / Prostaglandin G2 / Arachidonic Acid |
| Lumiracoxib Predicted Metabolism Pathway |  | Metabolic | Lumiracoxib / Mesoheme |
| Lurasidone Dopamine Antagonist Action Pathway |  | Drug Action | Pyridoxal phosphate / Tyrosine / Sapropterin / Dopamine / Levodopa / Calcium / Iron / Lurasidone |
| Lurasidone Predicted Metabolism Pathway |  | Metabolic | Mesoheme / Lurasidone |
| Lurasidone Serotonin Antagonist Action Pathway |  | Drug Action | Pyridoxal phosphate / Tryptophan / Sapropterin / Calcium / Iron / Oxitriptan / Lurasidone |
| Lymecycline Action Pathway |  | Drug Action | Lymecycline |
| Lymecycline Anti-Bacterial Action Pathway |  | Drug Action | Lymecycline |
| Lysine Degradation |  | Metabolic | Pyridoxal phosphate / Lysine / Glutamic acid / NADH / Oxogluric acid / Flavin adenine dinucleotide / L-Saccharopine |
| Lysinuric Protein Intolerance |  | Disease | Cysteine / Potassium cation / Urea |
| Lysinuric Protein Intolerance (LPI) |  | Disease | Cysteine / Potassium cation / Urea |
| Lysophosphatidic Acid LPA1 Signalling |  | Signaling | ATP / Calcium / Magnesium cation / Cyclic adenosine monophosphate / Pyrophosphoric acid |
| Lysophosphatidic Acid LPA2 Signalling |  | Signaling | ATP / Calcium / Magnesium cation / Cyclic adenosine monophosphate / Pyrophosphoric acid |
| Lysophosphatidic Acid LPA3 Signalling |  | Signaling | ATP / Calcium / Magnesium cation / Cyclic adenosine monophosphate / Pyrophosphoric acid |
| Lysophosphatidic Acid LPA4 Signalling |  | Signaling | ATP / Calcium / Magnesium cation / Cyclic adenosine monophosphate / Pyrophosphoric acid |
| Lysophosphatidic Acid LPA5 Signalling |  | Signaling | ATP / Calcium / Magnesium cation / Cyclic adenosine monophosphate / Pyrophosphoric acid |
| Lysophosphatidic Acid LPA6 Signalling |  | Signaling | ATP / Magnesium cation / Cyclic adenosine monophosphate / Pyrophosphoric acid |
| Lysosomal Acid Lipase Deficiency (Wolman Disease) |  | Disease | Cholecalciferol / ATP / Magnesium cation / Iron / Dimethylallyl Diphosphate / Formic acid / Geranyl Diphosphate / Mesoheme / Flavin adenine dinucleotide / Palmitic Acid / Pyrophosphoric acid / Cholesterol / ISOPENTENYL PYROPHOSPHATE / Farnesyl diphosphate |
| Lysosomal Acid Lipase Deficiency (Wolman Disease) |  | Disease | Cholecalciferol / ATP / Magnesium cation / Iron / Dimethylallyl Diphosphate / Formic acid / Geranyl Diphosphate / Mesoheme / Flavin adenine dinucleotide / Palmitic Acid / Pyrophosphoric acid / Cholesterol / ISOPENTENYL PYROPHOSPHATE / Farnesyl diphosphate |
| Macimorelin Predicted Metabolism Pathway |  | Metabolic | Mesoheme / Macimorelin |